Drug
Teneligliptin clinical trials
Also written MP-513.
- studies test it
- 24
- open now
- 0
- in phase 3
- 13
- first study started
- 2008
How studies write it
Studies that test it under each name
Name
Development codes
Combined with it in one product
Studies by the year they started
24 studies that test it; most in 2015 (4)
| Year | Studies |
|---|---|
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2012 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 4
- Phase 2
- 1
- Phase 3
- 13
- Phase 4
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 22 · Other 2
Handok Inc. (12) · Tanabe Pharma Corporation (10) · Yonsei University (1) · National Cerebral and Cardiovascular Center, Japan (1)
Often tested with
Tested in the same studies.
Canagliflozin (1) · Sulfonylurea Antidiabetic Agent (1) · N,N''-sulfonylbis-urea (1) · Insulin (1) · Empagliflozin (1) · Atorvastatin (1) · Metformin (1) · Glimepiride (1)
Studies
Open first, then newest update. How each study uses teneligliptin is read from its arms, and is right about nine times in ten.
Testing it · 24
- Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin)CompletedPhase 3Tanabe Pharma CorporationNCT02354222Written as Teneligliptin
- Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 DiabetesCompletedPhase 3Tanabe Pharma CorporationNCT02220907Written as Teneligliptin/Canagliflozin
- Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes MellitusCompletedPhase 3Tanabe Pharma CorporationNCT02916706Written as Teneligliptin 20mg
- Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes MellitusCompletedPhase 3Tanabe Pharma CorporationNCT02924064Written as Teneligliptin 20mg
- Efficacy and Safety Study of MP-513 in Combination With Sulfonylurea in Patients With Type 2 DiabetesCompletedPhase 3Tanabe Pharma CorporationNCT00974090Written as Placebo / Teneli (Teneligliptin) + SU (Sulfonylurea)
- Long-term Safety Study of MP-513 as Monotherapy or in Combination With Sulfonylurea in Japanese Type 2 Diabetic PatientsCompletedPhase 3Tanabe Pharma CorporationNCT02314637Written as Teneligliptin
- Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes MellitusCompletedPhase 3Tanabe Pharma CorporationNCT01072331Written as MP-513
- Monotherapy Study of MP-513 in Patients With Type 2 DiabetesCompletedPhase 3Tanabe Pharma CorporationNCT00998881Written as Teneligliptin 20 mg
- Efficacy and Safety Study of MP-513 in Patients With Type 2 DiabetesCompletedPhase 2Tanabe Pharma CorporationNCT00628212Written as Teneligliptin 10mg
- Efficacy and Safety Study of Teneligliptin (MP-513) in Combination With Insulin in Patients With Type 2 DiabetesCompletedPhase 4Tanabe Pharma CorporationNCT02081599Written as Teneli (Teneligliptin)
- Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and MetforminCompletedPhase 3Handok Inc.NCT05504226Written as Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral Tablet
- Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)CompletedPhase 4Handok Inc.NCT02512523Written as Teneligliptin
- Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and MetforminCompletedPhase 3Handok Inc.NCT05504239Written as Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral Tablet
- Tenelia Elderly CGMS Study(TEDDY)CompletedPhase 4Handok Inc.NCT03508323Written as Teneligliptin
- Pharmacokinetic Drug Interaction Between Teneligliptin and EmpagliflozinCompletedPhase 1Handok Inc.NCT04431141Written as Teneligliptin
- A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Type 2 DM After Failure of an Oral Triple Anti-diabetic RegimenCompletedPhase 4Yonsei UniversityNCT04446026Written as teneligliptin
- Teneligliptin and Atorvastatin DDI StudyCompletedPhase 1Handok Inc.NCT03769870Written as Teneligliptin 20mg/day
- Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two PatientsCompletedPhase 4Handok Inc.NCT03011177Written as Teneligliptin
- A Study to Compare MP-513 20mg & Metformin XR 1000mg FDC With Coadministration of the Two Separate DrugsCompletedPhase 1Handok Inc.NCT03787017Written as MP-513 20mg
- Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction With Type 2 Diabetes Mellitus StudyStatus unknownPhase 4National Cerebral and Cardiovascular Center, JapanNCT02449330Written as Teneligliptin
See all 24 studies that test teneligliptin →
Given in every arm · 2 — teneligliptin is usual care beside what is tested
- Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin)CompletedPhase 3Tanabe Pharma CorporationNCT02354235Written as Teneligliptin
- Long-term Safety Study of MP-513 in Patients With Type 2 DiabetesCompletedPhase 3Tanabe Pharma CorporationNCT01301833Written as teneligliptin
As the comparator · 3 — what is tested is compared with teneligliptin
- Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy VolunteersCompletedPhase 1Handok Inc.NCT07102719Written as Teneligliptin and Empagliflozin
- Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy VolunteersCompletedPhase 1Handok Inc.NCT06889350Written as Teneligliptin
- Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy VolunteersCompletedPhase 1Handok Inc.NCT06339788Written as Teneligliptin
Codes
What other systems call teneligliptin · ClinicalTrials.gg INT006250
- UNII (FDA) 28ZHI4CF9CTENELIGLIPTINConfirmed FDA, Wikidata
- Wikidata Q15269678teneligliptinConfirmed FDA, Wikidata
- NCI Thesaurus C87623TeneligliptinOne source FDA
- DrugBank DB11950One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | 28ZHI4CF9C | TENELIGLIPTIN | Confirmed FDA, Wikidata |
| Wikidata | Q15269678 | teneligliptin | Confirmed FDA, Wikidata |
| NCI Thesaurus | C87623 | Teneligliptin | One source FDA |
| DrugBank | DB11950 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.